These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 12680248)
1. Aspirin and methylsulfonylmethane (MSM): a search for common mechanisms, with implications for cancer prevention. Ebisuzaki K Anticancer Res; 2003; 23(1A):453-8. PubMed ID: 12680248 [TBL] [Abstract][Full Text] [Related]
2. NF-kappaB, macrophage migration inhibitory factor and cyclooxygenase-inhibitions as likely mechanisms behind the acetaminophen- and NSAID-prevention of the ovarian cancer. Altinoz MA; Korkmaz R Neoplasma; 2004; 51(4):239-47. PubMed ID: 15254653 [TBL] [Abstract][Full Text] [Related]
4. Chemopreventive activity of parthenolide against UVB-induced skin cancer and its mechanisms. Won YK; Ong CN; Shi X; Shen HM Carcinogenesis; 2004 Aug; 25(8):1449-58. PubMed ID: 15033901 [TBL] [Abstract][Full Text] [Related]
6. Prostaglandin-independent effects of aspirin on cell cycle and putrescine synthesis in human colon carcinoma cells. Eklou-Kalonji E; Andriamihaja M; Reinaud P; Mayeur C; Camous S; Robert V; Charpigny G; Blachier F Can J Physiol Pharmacol; 2003 May; 81(5):443-50. PubMed ID: 12774850 [TBL] [Abstract][Full Text] [Related]
7. The effects of L-748706, a selective cyclooxygenase-2 inhibitor, on N-nitrosomethylbenzylamine-induced rat esophageal tumorigenesis. Stoner GD; Qin H; Chen T; Carlton PS; Rose ME; Aziz RM; Dixit R Carcinogenesis; 2005 Sep; 26(9):1590-5. PubMed ID: 15878914 [TBL] [Abstract][Full Text] [Related]
8. Anti-inflammatory effect of two isoforms of COX in H. pylori-induced gastritis in mice: possible involvement of PGE2. Tanigawa T; Watanabe T; Hamaguchi M; Sasaki E; Tominaga K; Fujiwara Y; Oshitani N; Matsumoto T; Higuchi K; Arakawa T Am J Physiol Gastrointest Liver Physiol; 2004 Jan; 286(1):G148-56. PubMed ID: 12958020 [TBL] [Abstract][Full Text] [Related]
9. Regression of mouse prostatic intraepithelial neoplasia by nonsteroidal anti-inflammatory drugs in the transgenic adenocarcinoma mouse prostate model. Narayanan BA; Narayanan NK; Pittman B; Reddy BS Clin Cancer Res; 2004 Nov; 10(22):7727-37. PubMed ID: 15570007 [TBL] [Abstract][Full Text] [Related]
10. Aspirin, but not NO-releasing aspirin (NCX-4016), interacts with selective COX-2 inhibitors to aggravate gastric damage and inflammation. Wallace JL; Zamuner SR; McKnight W; Dicay M; Mencarelli A; del Soldato P; Fiorucci S Am J Physiol Gastrointest Liver Physiol; 2004 Jan; 286(1):G76-81. PubMed ID: 14665439 [TBL] [Abstract][Full Text] [Related]
11. NSAID inhibition of GI cancer growth: clinical implications and molecular mechanisms of action. Husain SS; Szabo IL; Tamawski AS Am J Gastroenterol; 2002 Mar; 97(3):542-53. PubMed ID: 11922545 [TBL] [Abstract][Full Text] [Related]
13. Phosphatidylcholine-associated nonsteroidal anti-inflammatory drugs (NSAIDs) inhibit DNA synthesis and the growth of colon cancer cells in vitro. Dial EJ; Doyen JR; Lichtenberger LM Cancer Chemother Pharmacol; 2006 Feb; 57(3):295-300. PubMed ID: 16032431 [TBL] [Abstract][Full Text] [Related]
14. Analysis of the nonsteroidal anti-inflammatory drug literature for potential developmental toxicity in rats and rabbits. Cook JC; Jacobson CF; Gao F; Tassinari MS; Hurtt ME; DeSesso JM Birth Defects Res B Dev Reprod Toxicol; 2003 Feb; 68(1):5-26. PubMed ID: 12852480 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of cutaneous ultraviolet light B-mediated inflammation and tumor formation with topical celecoxib treatment. Wilgus TA; Koki AT; Zweifel BS; Kusewitt DF; Rubal PA; Oberyszyn TM Mol Carcinog; 2003 Oct; 38(2):49-58. PubMed ID: 14502644 [TBL] [Abstract][Full Text] [Related]
16. Nonsteroidal anti-inflammatory agents differ in their ability to suppress NF-kappaB activation, inhibition of expression of cyclooxygenase-2 and cyclin D1, and abrogation of tumor cell proliferation. Takada Y; Bhardwaj A; Potdar P; Aggarwal BB Oncogene; 2004 Dec; 23(57):9247-58. PubMed ID: 15489888 [TBL] [Abstract][Full Text] [Related]
17. Kinetic modelling of NSAID action on COX-1: focus on in vitro/in vivo aspects and drug combinations. Goltsov A; Maryashkin A; Swat M; Kosinsky Y; Humphery-Smith I; Demin O; Goryanin I; Lebedeva G Eur J Pharm Sci; 2009 Jan; 36(1):122-36. PubMed ID: 19028575 [TBL] [Abstract][Full Text] [Related]